XML 77 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Compensation  
Schedule of stock option activity

Year Ended December 31,

 

2022

2021

2020

 

Weighted

Weighted

Weighted

 

Average

Average

Average

 

Exercise

Exercise

Exercise

 

Shares

Price

Shares

Price

Shares

Price

 

Outstanding at January 1, 2022

    

185,125

    

$

63.03

    

256,425

    

$

59.01

    

176,888

    

$

67.14

Assumed stock options and warrants from ACBI merger

23,410

40.73

136,831

37.85

Exercised

 

(43,525)

 

41.16

(64,075)

 

45.35

(52,331)

 

32.12

Forfeited

 

(356)

 

38.31

(6,250)

 

85.42

(4,963)

 

48.89

Expired

 

(2,822)

 

36.98

(975)

 

24.37

 

Outstanding at December 31, 2022

 

161,832

 

66.20

185,125

 

63.03

256,425

 

59.01

Exercisable at December 31, 2022

 

161,832

 

66.20

185,125

 

63.03

256,425

 

59.01

Schedule of information pertaining to options outstanding

Options Outstanding

Options Exercisable

Weighted

Weighted

Average

Average

Remaining

Weighted

Remaining

Weighted

Range of

Number

Contractual

Average

Number

Contractual

Average

Exercise Prices

Outstanding

Life

Exercise Price

Outstanding

Life

Exercise Price

$

23.19

-

$

40.00

    

13,811

    

1.1

years

$

35.36

    

13,811

1.1

years

$

35.36

$

40.01

-

$

55.00

 

40,449

 

3.4

years

$

44.64

 

40,449

3.4

years

$

44.64

$

55.01

-

$

70.00

 

50,403

 

2.1

years

$

63.68

 

50,403

2.1

years

$

63.68

$

85.01

-

$

91.35

 

57,169

 

4.6

years

$

91.12

57,169

4.6

years

$

91.12

 

161,832

 

3.2

years

$

66.20

 

161,832

3.2

years

$

66.20

Summary of nonvested restricted stock

    

    

Weighted-

 

Average

 

Grant-Date

 

Restricted Stock

Shares

Fair Value

 

Nonvested at January 1, 2022

 

3,066

$

67.31

Assumed restricted stock shares from ACBI merger

84,224

90.00

Vested

 

(31,416)

 

89.21

Forfeited

 

(5,368)

 

90.00

Nonvested at December 31, 2022

 

50,506

$

89.12

Vesting schedule of shares

    

Shares

 

2023

 

30,610

2024

 

14,107

2025

 

5,789

 

50,506

Summary of nonvested RSUs

    

    

Weighted-

 

Average

 

Grant-Date

 

Restricted Stock Units

Shares

Fair Value

 

Outstanding at January 1, 2022

 

948,213

$

67.01

Assumed restricted stock units from ACBI merger

55,736

87.94

Granted

 

338,500

 

82.30

Vested

(393,730)

66.49

Forfeited

(8,207)

83.38

Outstanding at December 31, 2022

 

940,512

$

73.82